Results 101 to 110 of about 17,189 (155)

People Living with HIV Eligibility in Canadian Cancer Clinical Trials. [PDF]

Curr Oncol
Comelles MF, Perez-Patrigeon S, Senneker T, Johnson A, Hicks LK, Balneaves L, Chen BE, Hay AE.   +7 more
europepmc   +1 more source

Multi-Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis. [PDF]

Arthritis Rheumatol
Smith MA, Sinibaldi D, Rahman S, Chiang CC, Hansen AM, Henault J, Roca CP, Wang S, Zerrouki K, Filippi R, Groves C, Manna Z, Chu J, Davis M, Gupta S, Morehouse C, de Los Reyes M, Ettinger R, Kolbeck R, Kaplan MJ, Sanjuan MA, Siegel RM, Hasni SA, Casey KA.   +23 more
europepmc   +1 more source

Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience. [PDF]

J Natl Cancer Inst
Sousa LG, Edward Bates J, Anand P, Caudell JJ, Colevas AD, Runge CL, Sharon JD, Awan M, Beadle BM, Choe JH, Gidley PW, Harari PM, Henson C, Katzel JA, Lee NY, McDowell L, Mell LK, Nader ME, Rudra S, Wang K, Yang G, Yom SS, Wise-Draper TM.   +22 more
europepmc   +1 more source

The Impact of Design Misspecifications on Survival Outcomes in Cancer Clinical Trials. [PDF]

Cancers (Basel)
Ou FS, Zemla T, Le-Rademacher JG.
europepmc   +1 more source

Can conservation drainage practices contribute to climate change mitigation? [PDF]

J Environ Qual
Hall SJ, Frankenberger JR, Christianson LE, Groh TA, Davis MP.   +4 more
europepmc   +1 more source

Stimulant Medications and Bone Health. [PDF]

Curr Osteoporos Rep
Swanson CM, Wolfe JH, Calarge CA.
europepmc   +1 more source

Predictive model for postoperative hyperalgesia in patients with lower limb fractures undergoing nerve block surgery. [PDF]

Pak J Med Sci
Pang P, Xu H, Du W, Dong F.
europepmc   +1 more source

Redefining Difficult-to-Treat Systemic Lupus Erythematosus: Biomarkers of Molecular Refractoriness Beyond Clinical Failure. [PDF]

Int J Mol Sci
Matusiewicz A, Paś A, Wiktorzak S, Olesińska M.   +3 more
europepmc   +1 more source

Validation of an agent-based model for cell interactions in a microfluidic chip. [PDF]

PLoS One
Panunzi S, Pompa M, D'Angelo PM, Bretti G, De Gaetano A.   +4 more
europepmc   +1 more source

Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials. [PDF]

Curr Oncol
Belloni S, Tiberio P, Mencaglia E, Brera AS, Giacon C, Benvenuti C, Jacobs F, Gaudio M, Torrisi R, Santoro A, Caruso R, Arrigoni C, Zambelli A, De Sanctis R.   +13 more
europepmc   +1 more source